Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine Augmentation Therapy in Schizophrenia
2014-003008-53Phase 3Active
- Sponsor
- University Medical Center Utrecht
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in schizophrenia, schizophreniform disorder and schizoaffective disorder comparing Clonidine augmentation with Placebo augmentation (2 arms). Primary endpoint: Change in PANSS total score. Started Sep 2014; status: active.
02
Drugs
clonidine
03
Conditions
schizophreniaschizophreniform disorderschizoaffective disorder
Beyond the preview
Go deeper on 2014-003008-53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003008-53.